carotids   Pertinent Results: [**2109-7-12**] WBC-26.4*# RBC-3.08*# Hgb-9.7*# Hct-28.6*# MCV-93 MCH-31.4 MCHC-33.8 RDW-12.7 Plt Ct-179 [**2109-7-14**] WBC-19.1* RBC-2.90* Hgb-9.2* Hct-27.0* MCV-93 MCH-31.8 MCHC-34.2 RDW-13.2 Plt Ct-198 [**2109-7-15**] WBC-14.1* RBC-2.86* Hgb-9.2* Hct-26.6* MCV-93 MCH-32.1* MCHC-34.5 RDW-13.2 Plt Ct-213 [**2109-7-16**] WBC-9.8 RBC-2.68* Hgb-8.3* Hct-25.2* MCV-94 MCH-31.0 MCHC-32.9 RDW-13.4 Plt Ct-266 [**2109-7-13**] Glucose-131* UreaN-11 Creat-0.6 Na-137 K-4.7 Cl-109* HCO3-21* [**2109-7-14**] Glucose-96 UreaN-9 Creat-0.7 Na-135 K-4.2 Cl-103 HCO3-24 [**2109-7-15**] Glucose-137* UreaN-10 Creat-0.7 Na-138 K-4.0 Cl-102 HCO3-27 [**2109-7-14**] PT-15.5* PTT-28.9 INR(PT)-1.4* [**2109-7-15**] PT-27.8* PTT-52.5* INR(PT)-2.7* [**2109-7-15**] PT-28.0* PTT-31.0 INR(PT)-2.7* [**2109-7-16**] PT-30.9* PTT-33.2 INR(PT)-3.1*   Brief Hospital Course: Ms. [**Known lastname 3234**] was admitted to [**Hospital1 18**] on [**2109-7-12**] and taken to the operating room for aortic and mitral valve replacements with St. [**Male First Name (un) 923**] mechanical valves.
Once her INR was therapeutic, the heparin drip was discontinued.
Her INR will be followed by Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] in [**Company 191**] coumadin clinic.
Warfarin 2.5 mg Tablet Sig: One (1) Tablet PO once a day: Warfarin should be titrated for goal INR between 2.5 - 3.5.
3)  Report any weight gain of 2 pounds in 24 hours or 5 pounds in 1 week.
Warfarin should be titrated for goal INR between 2.5 - 3.5.
Followup Instructions: - Dr. [**First Name (STitle) **] [**Name (STitle) **] in 4 weeks [**Telephone/Fax (1) 170**] - Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] (PCP) in [**2-19**] weeks - Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 171**] (cardiologist) in 2 weeks - Wound check on [**Hospital Ward Name **] 6 as scheduled by [**Hospital Ward Name 121**] 6 nurses - First INR check should be on [**2109-7-18**].
